Generation Bio Co
GBIO4.535USD
+0.325+7.72%
交易中 （美東）報價延遲15分鐘
303.88M總市值
虧損本益比TTM
關於 Generation Bio Co 公司
Generation Bio Co. 是一家生物技術公司。該公司正在創新非病毒基因藥物，爲數億患有罕見和流行疾病的患者提供持久、可重複使用的治療方法。該公司正在開發兩個獨特且互補的平臺：一種強效、高選擇性的細胞靶向脂質納米顆粒 (ctLNP) 遞送系統和一種新型免疫靜默 DNA (iqDNA) 貨物，後者採用可擴展的無衣殼製造工藝生產，該工藝使用專有的無細胞快速酶合成 (RES)。該公司正在推進一系列項目，這些項目以強效和高選擇性的信使核糖核酸 (mRNA) 和/或 iqDNA 遞送爲指導，使用其 ctLNP 遞送系統靶向 T 細胞、造血幹細胞 (HSC) 和肝細胞，並打算擴展到其他組織和細胞類型。其在 T 細胞方面的工作重點是體內重新編程這種細胞類型以治療癌症和自身免疫性疾病。
公司簡介
公司代碼GBIO
公司名稱Generation Bio Co
上市日期Jun 12, 2020
CEODr. Cameron Geoffrey (Geoff) Mcdonough, M.D.
員工數量115
證券類型Ordinary Share
年結日Jun 12
公司地址301 Binney Street
城市CAMBRIDGE
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編02142
電話18575295908
網址https://generationbio.com/
公司代碼GBIO
上市日期Jun 12, 2020
CEODr. Cameron Geoffrey (Geoff) Mcdonough, M.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Cameron Geoffrey (Geoff) Mcdonough, M.D.
Dr. Cameron Geoffrey (Geoff) Mcdonough, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
185.48K
+0.20%
Dr. Anthony G. Quinn, M.D., Ph.D.
Dr. Anthony G. Quinn, M.D., Ph.D.
Independent Director
Independent Director
37.21K
--
Mr. Gustav A. Christensen
Mr. Gustav A. Christensen
Independent Director
Independent Director
13.14K
--
Dr. Phillip Samayoa, Ph.D.
Dr. Phillip Samayoa, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
12.93K
+0.63%
Ms. Yalonda Howze, J.D.
Ms. Yalonda Howze, J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
6.70K
+3.67%
Dr. Catherine Stehman-Breen, M.D.
Dr. Catherine Stehman-Breen, M.D.
Independent Director
Independent Director
4.75K
--
Ms. Dannielle Appelhans
Ms. Dannielle Appelhans
Independent Director
Independent Director
2.00K
+150.00%
Mr. Kevin John Conway
Mr. Kevin John Conway
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
1.83K
+2.35%
Mr. Ronald Harold Wilfred (Ron) Cooper
Mr. Ronald Harold Wilfred (Ron) Cooper
Independent Director
Independent Director
950.00
--
Mr. Jason Rhodes
Mr. Jason Rhodes
Independent Chairman of the Board
Independent Chairman of the Board
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Cameron Geoffrey (Geoff) Mcdonough, M.D.
Dr. Cameron Geoffrey (Geoff) Mcdonough, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
185.48K
+0.20%
Dr. Anthony G. Quinn, M.D., Ph.D.
Dr. Anthony G. Quinn, M.D., Ph.D.
Independent Director
Independent Director
37.21K
--
Mr. Gustav A. Christensen
Mr. Gustav A. Christensen
Independent Director
Independent Director
13.14K
--
Dr. Phillip Samayoa, Ph.D.
Dr. Phillip Samayoa, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
12.93K
+0.63%
Ms. Yalonda Howze, J.D.
Ms. Yalonda Howze, J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
6.70K
+3.67%
Dr. Catherine Stehman-Breen, M.D.
Dr. Catherine Stehman-Breen, M.D.
Independent Director
Independent Director
4.75K
--
收入明細
FY2024
FY2023
暫無數據
地區USD
名稱
營收
佔比
United States
19.89M
0.00%
業務
地區
暫無數據
股東統計
更新時間: 5月17日 週六
更新時間: 5月17日 週六
持股股東
股東類型
持股股東
持股股東
佔比
T. Rowe Price Associates, Inc.
13.25%
Atlas Venture
12.35%
Modernatx Inc
8.74%
Fidelity Management & Research Company LLC
7.09%
BlackRock Institutional Trust Company, N.A.
4.64%
Other
53.93%
持股股東
持股股東
佔比
T. Rowe Price Associates, Inc.
13.25%
Atlas Venture
12.35%
Modernatx Inc
8.74%
Fidelity Management & Research Company LLC
7.09%
BlackRock Institutional Trust Company, N.A.
4.64%
Other
53.93%
股東類型
持股股東
佔比
Investment Advisor
38.32%
Venture Capital
12.43%
Investment Advisor/Hedge Fund
9.30%
Corporation
8.74%
Hedge Fund
6.59%
Individual Investor
5.64%
Research Firm
5.05%
Family Office
0.13%
Bank and Trust
0.09%
Other
13.72%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
204
5.77M
86.15%
-1.71M
2025Q1
216
58.42M
87.25%
-16.87M
2024Q4
239
64.26M
96.22%
-10.38M
2024Q3
252
65.74M
98.51%
-9.46M
2024Q2
257
65.96M
99.11%
-9.63M
2024Q1
256
65.28M
99.25%
-2.56M
2023Q4
262
62.66M
95.79%
-3.14M
2023Q3
260
66.58M
101.93%
-550.54K
2023Q2
272
66.62M
102.34%
-297.13K
2023Q1
283
66.66M
111.77%
+650.55K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
T. Rowe Price Associates, Inc.
8.88M
13.25%
-217.22K
-2.39%
Mar 31, 2025
Atlas Venture
8.28M
12.35%
--
--
Mar 31, 2025
Modernatx Inc
5.86M
8.74%
--
--
Apr 07, 2025
Fidelity Management & Research Company LLC
4.75M
7.09%
+126.37K
+2.73%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.11M
4.64%
-49.92K
-1.58%
Mar 31, 2025
Invus Public Equities Advisors, LLC
2.97M
4.43%
-13.81K
-0.46%
Mar 31, 2025
The Vanguard Group, Inc.
2.62M
3.91%
-22.29K
-0.84%
Mar 31, 2025
Baker Bros. Advisors LP
1.94M
2.9%
--
--
Mar 31, 2025
Renaissance Technologies LLC
1.88M
2.81%
+917.71K
+95.30%
Mar 31, 2025
McDonough (Cameron Geoffrey)
1.85M
2.76%
+15.31K
+0.83%
Apr 15, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Proshares Ultra Russell 2000
0%
Global X Russell 2000 Covered Call ETF
0%
iShares Micro-Cap ETF
0%
iShares Russell 2000 ETF
0%
iShares Biotechnology ETF
0%
Avantis US Small Cap Equity ETF
0%
Fidelity Blue Chip Growth ETF
0%
Avantis US Equity ETF
0%
ProShares Ultra Nasdaq Biotechnology
0%
Invesco RAFI US 1500 Small-Mid ETF
0%
查看更多
Proshares Ultra Russell 2000
佔比0%
Global X Russell 2000 Covered Call ETF
佔比0%
iShares Micro-Cap ETF
佔比0%
iShares Russell 2000 ETF
佔比0%
iShares Biotechnology ETF
佔比0%
Avantis US Small Cap Equity ETF
佔比0%
Fidelity Blue Chip Growth ETF
佔比0%
Avantis US Equity ETF
佔比0%
ProShares Ultra Nasdaq Biotechnology
佔比0%
Invesco RAFI US 1500 Small-Mid ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
